L&K Biomed Ltd. (KOSDAQ:156100)

L&K Biomed Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5,238	3,835	5,047	7,395	16,108	4,910
Short-Term Investments	8,108	16,108	7,729	5,608	3,108	3,306
Cash & Short-Term Investments	13,346	19,943	12,776	13,003	19,216	8,216
Cash Growth	-40.77%	56.10%	-1.75%	-32.33%	133.88%	68.81%
Accounts Receivable	16,302	14,980	9,839	5,780	1,526	3,084
Other Receivables	377.22	290.26	1,066	223.05	635.92	203.53
Receivables	17,277	16,015	10,905	6,003	2,162	3,309
Inventory	28,113	24,551	19,089	16,366	13,856	19,358
Prepaid Expenses	739.93	525.95	656.55	444.63	688.1	310.2
Other Current Assets	1,072	2,532	990.85	330.62	2,042	851.06
Total Current Assets	60,548	63,566	44,417	36,147	37,964	32,044
Property, Plant & Equipment	8,897	10,005	9,012	8,514	9,271	7,890
Long-Term Investments	592.08	577.5	1,049	64.15	1,203	1,755
Goodwill	-	-	-	-	-	244.11
Other Intangible Assets	969.47	998.17	798.73	715.11	1,209	836.23
Long-Term Accounts Receivable	2,625	1,807	1,281	2,385	5,200	5,006
Long-Term Deferred Tax Assets	4,933	5,009	5,516	3,902	3,591	8,515
Long-Term Deferred Charges	-	-	-	106.09	223.63	427.86
Other Long-Term Assets	1,375	798.55	387.38	829.96	623.29	2,278
Total Assets	80,238	83,061	62,762	52,663	59,285	58,995
Accounts Payable	2,709	3,347	2,047	2,437	498.73	1,384
Accrued Expenses	579.3	851.44	685.87	589.86	606.95	791.83
Short-Term Debt	20,550	20,558	10,040	20,406	6,692	12,434
Current Portion of Long-Term Debt	800	800	100	2,800	-	3,128
Current Portion of Leases	832.35	669.07	828.69	750.57	636.63	572.79
Current Income Taxes Payable	3.26	7.29	0.35	54.09	0.89	3.59
Other Current Liabilities	11,002	12,841	9,062	10,943	4,177	1,350
Total Current Liabilities	36,476	39,074	22,763	37,981	12,613	19,664
Long-Term Debt	1,000	1,000	1,700	-	13,608	2,100
Long-Term Leases	898.39	369.63	845.16	1,244	1,518	1,751
Long-Term Deferred Tax Liabilities	1,393	1,569	1,361	1,047	-	-
Other Long-Term Liabilities	119.22	1,958	3,274	55.37	5,429	54.28
Total Liabilities	43,206	47,028	32,175	41,902	34,499	24,832
Common Stock	9,968	9,968	9,968	6,703	6,696	6,635
Additional Paid-In Capital	56,477	90,386	90,386	68,174	67,992	63,616
Retained Earnings	-27,959	-58,746	-67,849	-65,348	-51,884	-40,051
Treasury Stock	-0.09	-0.09	-0.09	-0.09	-0.09	-0.09
Comprehensive Income & Other	4,185	887.93	2,846	2,740	1,663	1,415
Total Common Equity	42,671	42,496	35,351	12,268	24,467	31,615
Minority Interest	-5,640	-6,463	-4,764	-1,507	319.82	2,548
Shareholders' Equity	37,032	36,033	30,587	10,762	24,787	34,163
Total Liabilities & Equity	80,238	83,061	62,762	52,663	59,285	58,995
Total Debt	24,081	23,397	13,513	25,201	22,456	19,986
Net Cash (Debt)	-10,735	-3,454	-737.76	-12,198	-3,240	-11,770
Net Cash Per Share	-499.04	-160.55	-45.50	-910.57	-242.05	-989.82
Filing Date Shares Outstanding	19.94	19.94	19.94	13.41	13.39	13.24
Total Common Shares Outstanding	19.94	19.94	19.94	13.41	13.39	13.27
Working Capital	24,072	24,492	21,654	-1,834	25,351	12,380
Book Value Per Share	2140.34	2131.56	1773.17	915.17	1826.89	2382.37
Tangible Book Value	41,702	41,498	34,553	11,553	23,258	30,534
Tangible Book Value Per Share	2091.71	2081.50	1733.11	861.82	1736.61	2300.96
Land	737.02	737.02	737.02	737.02	737.02	1,079
Buildings	2,502	2,502	2,502	2,502	2,502	3,682
Machinery	16,074	16,491	14,307	12,330	11,671	5,884
Construction In Progress	236.05	59	-	-	-	225.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.